These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37646732)

  • 21. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling Insufficiency.
    Gopalakrishnan A; Richard K; Wahid R; Harley R; Sztein MB; Hawkins LD; Vogel SN
    J Immunol; 2022 Nov; 209(10):1950-1959. PubMed ID: 36426935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
    Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
    ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calix[
    da Silva Neto L; da Silva Maia AF; Godin AM; de Almeida Augusto PS; Pereira RLG; Caligiorne SM; Alves RB; Fernandes SOA; Cardoso VN; Goulart GAC; Martins FT; das Neves MCL; Garcia FD; de Fátima Â
    J Adv Res; 2022 May; 38():285-298. PubMed ID: 35572397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD; Bowen-Yacyshyn MB; Samuel J; Meikle A; Stuart G; Nation J; Poppema S; Jerry M; Koganty R; Wong T
    J Immunother (1991); 1992 May; 11(4):292-305. PubMed ID: 1599915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
    Dey AK; Srivastava IK
    Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
    Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
    J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potential vaccine for cocaine abuse prophylaxis?
    Gallacher G
    Immunopharmacology; 1994; 27(1):79-84. PubMed ID: 8206756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice.
    Tandon A; Pathak M; Harioudh MK; Ahmad S; Sayeed M; Afshan T; Siddiqi MI; Mitra K; Bhattacharya SM; Ghosh JK
    J Biol Chem; 2018 Dec; 293(51):19874-19885. PubMed ID: 30385503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes.
    Bettahi I; Dasgupta G; Renaudet O; Chentoufi AA; Zhang X; Carpenter D; Yoon S; Dumy P; BenMohamed L
    Cancer Immunol Immunother; 2009 Feb; 58(2):187-200. PubMed ID: 18584174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
    Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
    Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2.
    Ding D; Wen Y; Liao CM; Yin XG; Zhang RY; Wang J; Zhou SH; Zhang ZM; Zou YK; Gao XF; Wei HW; Yang GF; Guo J
    J Med Chem; 2023 Jan; 66(2):1467-1483. PubMed ID: 36625758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines.
    Skwarczynski M; Zhao G; Boer JC; Ozberk V; Azuar A; Cruz JG; Giddam AK; Khalil ZG; Pandey M; Shibu MA; Hussein WM; Nevagi RJ; Batzloff MR; Wells JW; Capon RJ; Plebanski M; Good MF; Toth I
    Sci Adv; 2020 Jan; 6(5):eaax2285. PubMed ID: 32064333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor effects of propranolol: Adjuvant activity on a transplanted murine breast cancer model.
    Ashrafi S; Shapouri R; Shirkhani A; Mahdavi M
    Biomed Pharmacother; 2018 Aug; 104():45-51. PubMed ID: 29758415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.
    Taylor JJ; Laudenbach M; Tucker AM; Jenkins MK; Pravetoni M
    J Immunol Methods; 2014 Mar; 405():74-86. PubMed ID: 24462800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects.
    Wee S; Hicks MJ; De BP; Rosenberg JB; Moreno AY; Kaminsky SM; Janda KD; Crystal RG; Koob GF
    Neuropsychopharmacology; 2012 Apr; 37(5):1083-91. PubMed ID: 21918504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.
    Dowling DJ; Barman S; Smith AJ; Borriello F; Chaney D; Brightman SE; Melhem G; Brook B; Menon M; Soni D; Schüller S; Siram K; Nanishi E; Bazin HG; Burkhart DJ; Levy O; Evans JT
    Sci Rep; 2022 Oct; 12(1):16860. PubMed ID: 36258023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.
    Cai X; Whitfield T; Hixon MS; Grant Y; Koob GF; Janda KD
    J Med Chem; 2013 May; 56(9):3701-9. PubMed ID: 23627877
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.